FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - BOERSE MUENCHEN 14:26:58 2024-06-28 EDT | ||
| 14.1 EUR | +1.73% |
|
| Current month | +13.16% | ||
| 1 month | +30.56% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 14.1 | +1.73% |
| 24-06-27 | 13.86 | -6.35% |
| 24-06-26 | 14.8 | -20.39% |
| 24-06-25 | 18.59 | +12.60% |
| 24-06-24 | 16.51 | +17.76% |
Real-time BOERSE MUENCHEN
Last update June 28, 2024 at 02:26 pm
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GP53AN |
| ISIN | DE000GP53AN2 |
| Date issued | 2023-05-30 |
| Strike | 282.3 $ |
| Maturity | Unlimited |
| Parity | 2.01 : 1 |
| Emission price | 8.71 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 82.05 € |
|---|---|
| Lowest since issue | 5.56 € |
| Spread | 0.2 € |
| Spread % | 1.40% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.4
USD
Average target price
316.4
USD
Spread / Average Target
+1.28%
- Stock Market
- Certificates
- Certificat
